MedPath

New Insights Into the Metabolic Syndrome: the Role of Alpha Defensin

Not Applicable
Conditions
Metabolic Syndrome
Registration Number
NCT03469115
Lead Sponsor
Hillel Yaffe Medical Center
Brief Summary

The purpose of this study is to find out if there is a connection between a higher level of peptide alpha defensin in blood serum with the metabolic profile of adolescents aged 13-17.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Youths with metabolic syndrome (BMI above 95%)
  • Youths with BMI below 3%
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Alpha defensin level2 hours

Alpha defensin level above 12ng/microliter

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hille Yaffe Medical Center

🇮🇱

Hadera, Israel

Hille Yaffe Medical Center
🇮🇱Hadera, Israel
Eias Kassem, MD
Contact
eiask@hy.health.gov.il

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.